Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank
نویسندگان
چکیده
Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank J. McLauchlan, H. Innes,* J.F. Dillon, G. Foster, E. Holtham, S. McDonald, B. Wilkes, S.J. Hutchinson and W.L. Irving on behalf of the HCV Research UK Steering Committee MRC-University of Glasgow Centre for Virus Research, Glasgow, UK, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK, Blood Borne Viruses and STIs Division, Health Protection Scotland, Glasgow, UK, Division of Molecular and Clinical Medicine; University of Dundee, Dundee, UK, Institute of Cell and Molecular Science, Queen Mary University of London, London, UK and National Institute for Health Research (NIHR) Digestive Diseases Biomedical Research Unit at Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
منابع مشابه
Seroepidemiology and risk factors of hepatitis C virus infection in East Azerbaijan, Iran: a population-based Azar Cohort study
Background: Hepatitis C virus (HCV) is a blood-borne virus. It is a major global public health problem and can cause both acute and chronic hepatitis. The aim of this study was to report the epidemiological features of HCV infection and risk factors based on the data from Azar Cohort, East Azerbaijan province, Iran. Methods: The population of this study comprised the people in the age range of...
متن کاملAntiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus
Hepatitis C virus (HCV) has infected 3% of the population worldwide and 20% of the population in Egypt. HCV infection can lead to hepatocellular carcinoma and death. The presently available treatment with interferon plus ribavirin, has limited benefits due to adverse side effects. Seaweeds have become a major source of new compounds to treat viral diseases. This work aimed to study the effect o...
متن کاملAntiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus
Hepatitis C virus (HCV) has infected 3% of the population worldwide and 20% of the population in Egypt. HCV infection can lead to hepatocellular carcinoma and death. The presently available treatment with interferon plus ribavirin, has limited benefits due to adverse side effects. Seaweeds have become a major source of new compounds to treat viral diseases. This work aimed to study the effect o...
متن کاملSeroprevalence of Human Immunodificiency Virus (HIV) and Hepatitis C Infection In Hemophilic Patients In Iran
Background and Objective: Although transfusion therapy has lead to great improvement in longevity for hemophiliacs, but there have been tragic setbacks especially from transmission of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) .HIV was reported to increase the rate of HCV-related liver failure by 4.2 times. In this study, we aimed to determine the seroprevalence of HIV an...
متن کاملHepatitis C Virus and Vaccine Development
The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...
متن کامل